Evidence map›Paper›PMID 34852350›Full record

ArticleMedical principles and practice : international journal of the Kuwait University, Health Science Centre

Increased Circulating Copeptin Levels Are Associated with Vaso-Occlusive Crisis and Right Ventricular Dysfunction in Sickle Cell Anemia.

Onur Sinan Deveci, Caglar Ozmen, Muhammet Bugra Karaaslan, Aziz Inan Celik, Hatice Rahimova, Anil Akray, Omer Tepe, Emel Gurkan, Ali Deniz

Open access · diamondAbstract read
In one paragraph

Article in Medical principles and practice : international journal of the Kuwait University, Health Science Centre. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Onur Sinan DeveciDepartment of Cardiology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Caglar OzmenDepartment of Cardiology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Muhammet Bugra KaraaslanDepartment of Cardiology, Osmancik State Hospital, Corum, Turkey.
Aziz Inan CelikDepartment of Cardiology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Hatice RahimovaDepartment of Cardiology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Anil AkrayDepartment of Cardiology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Omer TepeDepartment of Cardiology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Emel GurkanDepartment of Hematology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Ali DenizDepartment of Cardiology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Cukurova University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveVaso-occlusive crisis (VOC) is a common clinical manifestation of sickle cell anemia (SCA) and is associated with increased proinflammatory mediators. Copeptin is the C-terminal part of the prohormone for provasopressin and seems clinically relevant in various clinical conditions. Right ventricular (RV) dysfunction significantly appears in SCA patients due to pulmonary hypertension. This study aimed to investigate the association of copeptin levels in VOC patients and evaluate RV dysfunction. MATERIALS AND

methodsA total of 108 patients were enrolled in the study. Twenty-eight SCA patients in steady state (30.2 ± 0.9 years), 25 SCA patients in VOC (36.8 ± 11.8 years), and 55 healthy individuals (31.9 ± 9.4 years) with HbAA genotype were included. Clinical, echocardiographic, and laboratory data were recorded. ELISA was used for the determination of serum levels of copeptin.

resultsVOC patients had significantly higher copeptin level compared both with controls and SCA subjects in steady state (22.6 ± 13.0 vs. 11.3 ± 5.7 pmol/L, 22.6 ± 13.0 vs. 12.4 ± 5.8 pmol/L, p = 0.009 for both). Additionally, the copeptin level was significantly higher in SCA patients with RV dysfunction than those without RV dysfunction (23.2 ± 12.2 vs. 15.3 ± 9.5 pmol/L, p = 0.024). Multiple logistic regression analysis revealed that high-sensitivity C-reactive protein and copeptin levels were found to be associated with VOC.

conclusionThis study showed that copeptin and hs-CRP levels were increased in patients with VOC, and it was found that RV dysfunction was more common in SCA patients with VOC than in the control group. Copeptin can be considered for use as a potential biomarker in predicting VOC crisis in SCA patients and in the early detection of patients with SCA who have the potential to develop RV dysfunction.

Indexed as

Anemia, Sickle CellGlycopeptidesVentricular Dysfunction, RightArterial Occlusive DiseasesBiomarkersC-Reactive ProteinHumansBiomarkerscopeptinsC-Reactive ProteinGlycopeptidesCopeptinRight ventricular dysfunctionSickle cell anemiaVaso-occlusive crisis

Identifiers

PMID34852350
PMCPMC8995666
OpenAlexW3215472672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.